Antimicrobial Agents Practice Questions

Q: Which of the following adverse effects is most likely to occur with sulfonamides?

Skin reactions. **Explanation:** **Sulfonamides** are structural analogs of PABA that inhibit dihydropteroate synthase. Their adverse effect profile is a high-yield topic for NEET-PG, with **hypersensitivity reactions** being the most frequent complication. 1. **Why Skin Reactions are Correct:** Skin reactions are the most common adverse effect of sulfonamides, ranging from mild rashes, urticaria, and photosensitivity to life-threatening conditions like **Stevens-Johnson Syndrome (SJS)** and **Toxic Epidermal Necrolysis (TEN)**. These are Type IV hypersensitivity reactions caused by the accumulation of reactive metabolites (hydroxylamines) in the skin. 2. **Analysis of Incorrect Options:** * **Neurologic effects (A):** While possible, these are rare and not the "most likely" or characteristic side effect compared to dermatological issues. * **Hematuria (B):** Sulfonamides can cause **crystalluria** (precipitation of the drug in acidic urine), which may lead to hematuria. However, this is largely prevented in modern practice by maintaining adequate hydration and urinary alkalinization, making it less common than skin reactions. * **Fanconi’s Anemia (C):** This is a genetic DNA repair defect. Sulfonamides do not cause Fanconi’s anemia, though they can cause **Aplastic Anemia** (rare) or **Hemolytic Anemia** specifically in patients with **G6PD deficiency**. **High-Yield Clinical Pearls for NEET-PG:** * **Kernicterus:** Sulfonamides displace bilirubin from albumin; they are contraindicated in newborns and near-term pregnancy. * **G6PD Deficiency:** Always remember the "Sulfas" (Sulfonamides, Sulfonylureas, Dapsone) as triggers for hemolysis. * **Drug Interactions:** They displace warfarin and phenytoin from plasma proteins, increasing their toxicity. * **Triple Sulfas:** Used historically to increase solubility and decrease the risk of crystalluria.

Q: Ganciclovir is preferred over acyclovir in which of the following conditions?

Cytomegalovirus retinitis in AIDS patients. **Explanation:** **1. Why Option D is Correct:** Ganciclovir is a synthetic analog of 2'-deoxyguanosine. While it shares a similar mechanism with acyclovir (inhibition of viral DNA polymerase), it is **10 to 100 times more potent against Cytomegalovirus (CMV)**. In CMV-infected cells, ganciclovir is monophosphorylated by a viral protein kinase called **UL97**, which allows it to reach much higher intracellular concentrations than acyclovir. Therefore, it is the drug of choice for life- or sight-threatening CMV infections, such as **CMV retinitis** in immunocompromised (AIDS) patients. **2. Why Other Options are Incorrect:** * **A, B, and C:** These conditions are caused by the Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV). **Acyclovir** is the preferred agent for these because it is highly effective and has a superior safety profile. Ganciclovir is significantly more toxic (causing bone marrow suppression) and is generally reserved for CMV, where acyclovir is ineffective. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Resistance:** Resistance to ganciclovir occurs due to mutations in the **UL97 gene** (preventing phosphorylation) or the viral DNA polymerase. * **Dose-Limiting Toxicity:** The most common side effect is **bone marrow suppression** (neutropenia and thrombocytopenia). This is additive if used with Zidovudine (AZT). * **Valganciclovir:** This is the L-valyl ester (prodrug) of ganciclovir with high oral bioavailability, often used for maintenance therapy in CMV retinitis. * **Foscarnet:** Used as a second-line agent for ganciclovir-resistant CMV; it does not require phosphorylation by viral kinases.

Q: Which aminoglycoside has the least toxic effect?

Streptomycin. **Explanation:** The correct answer is **Streptomycin**. Among the aminoglycosides listed, Streptomycin is considered the least toxic, particularly regarding its systemic side effect profile compared to older or more potent aminoglycosides like Kanamycin. **1. Why Streptomycin is correct:** Aminoglycosides are known for their "Big Three" toxicities: Ototoxicity, Nephrotoxicity, and Neuromuscular blockade. While all aminoglycosides carry these risks, Streptomycin is primarily **vestibulotoxic** rather than cochleotoxic or highly nephrotoxic. In clinical practice, especially within the RNTCP (tuberculosis) guidelines, it is tolerated relatively well compared to Kanamycin, which has a significantly higher incidence of permanent hearing loss and renal impairment. **2. Why the other options are incorrect:** * **Ethambutol:** This is not an aminoglycoside; it is an antimetabolite used in TB treatment. Its primary toxicity is optic neuritis. * **Isoniazid:** This is not an aminoglycoside; it is a prodrug that inhibits mycolic acid synthesis. Its primary toxicities are peripheral neuropathy and hepatitis. * **Kanamycin:** This is one of the most toxic aminoglycosides. It is highly **cochleotoxic** and **nephrotoxic**, which is why its clinical use has been largely superseded by Amikacin or Gentamicin. **3. NEET-PG High-Yield Pearls:** * **Most Nephrotoxic:** Neomycin (hence used only topically or orally for bowel prep). * **Most Ototoxic (Cochlear):** Kanamycin, Amikacin, Neomycin. * **Most Vestibulotoxic:** Streptomycin and Gentamicin. * **Mechanism of Action:** Irreversible inhibition of the 30S ribosomal subunit (bactericidal). * **Resistance Mechanism:** The most common method is the production of bacterial **inactivating enzymes** (adenylylation, acetylation, or phosphorylation).

Q: What is the mechanism of action of Delamanid?

Inhibition of Mycolic acid synthesis. **Explanation:** **Delamanid** is a newer anti-tubercular drug belonging to the **nitrodihydro-imidazooxazole** class. It is specifically used for the treatment of Multidrug-Resistant Tuberculosis (MDR-TB). **1. Why Option C is Correct:** Delamanid acts as a prodrug that is activated by the mycobacterial enzyme **deazaflavin-dependent nitroreductase (Ddn)**. Once activated, it inhibits the synthesis of **methoxy-mycolic and keto-mycolic acids**, which are essential components of the mycobacterial cell wall. By disrupting the cell wall integrity, it exerts a potent bactericidal effect against both intra- and extracellular *Mycobacterium tuberculosis*. **2. Why Other Options are Incorrect:** * **Option A & D (DNA Gyrase/Topoisomerase):** These are the targets of **Fluoroquinolones** (e.g., Moxifloxacin, Levofloxacin). They inhibit DNA replication by preventing the relaxation of supercoiled DNA. * **Option B (Alanine Racemase):** This is the mechanism of action of **Cycloserine**, a second-line anti-tubercular drug that inhibits cell wall synthesis by preventing the incorporation of D-alanine into the peptidoglycan pentapeptide. **Clinical Pearls for NEET-PG:** * **Bedaquiline vs. Delamanid:** While both are used for MDR-TB, Bedaquiline inhibits **ATP synthase**, whereas Delamanid inhibits **mycolic acid synthesis**. * **Adverse Effect:** The most significant side effect of Delamanid is **QT interval prolongation**. Caution is required when co-administering it with other QT-prolonging drugs like Bedaquiline or Fluoroquinolones. * **Metabolism:** Unlike many TB drugs, Delamanid is primarily metabolized by **albumin** (hydrolysis) rather than Cytochrome P450 enzymes, reducing the risk of certain drug-drug interactions.

Q: IV Metronidazole is used in the treatment of which of the following?

All of the above. **Explanation:** Metronidazole is a nitroimidazole derivative that acts by inhibiting DNA synthesis in anaerobic environments. It is the drug of choice for a wide range of anaerobic and protozoal infections. **Why "All of the above" is correct:** 1. **Pseudomembranous enterocolitis:** Caused by *Clostridioides difficile*, Metronidazole (IV or Oral) was traditionally the first-line treatment. While oral Vancomycin or Fidaxomicin are now preferred for initial episodes, IV Metronidazole remains a critical component in treating **severe/fulminant cases** (often combined with Vancomycin). 2. **Anaerobic bacterial infections:** Metronidazole is highly effective against Gram-negative anaerobes like *Bacteroides fragilis* and Gram-positive anaerobes like *Clostridium* species. It is used for intra-abdominal infections, brain abscesses, and aspiration pneumonia. 3. **Amoebiasis:** It is the drug of choice for invasive intestinal and extra-intestinal (liver abscess) amoebiasis caused by *Entamoeba histolytica*. In severe cases where oral intake is not possible, the IV route is utilized. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** It acts as an electron sink; its nitro group is reduced by the **pyruvate:ferredoxin oxidoreductase (PFOR)** system in anaerobes, creating toxic free radicals that cause DNA strand breakage. * **Disulfiram-like reaction:** Patients must avoid alcohol during and for 48 hours after treatment due to the inhibition of aldehyde dehydrogenase. * **Side Effects:** Metallic taste (most common), peripheral neuropathy (long-term use), and seizures. * **Drug of Choice for:** Trichomoniasis, Giardiasis, and Bacterial Vaginosis. * **Note:** It has **no activity** against aerobic bacteria.

Q: A 30-year-old male patient presents with a painful skin rash. Despite antiviral and analgesic treatment, his symptoms have not improved. Viral strains isolated from the patient lack viral phosphorylating enzymes. Which of the following drugs is most likely to be effective in treating this condition?

Foscarnet. ### Explanation The correct answer is **D. Foscarnet**. **Mechanism and Rationale:** The clinical scenario describes a viral infection (likely Herpes Simplex or Varicella-Zoster) resistant to standard therapy due to the absence of **viral phosphorylating enzymes** (e.g., **Thymidine Kinase** in HSV/VZV or UL97 kinase in CMV). Drugs like Acyclovir, Ganciclovir, and Famciclovir are **nucleoside analogs**. They are "prodrugs" that require a three-step phosphorylation to become active. The crucial first step is mediated by the viral enzyme (Thymidine Kinase). If the virus lacks this enzyme, these drugs cannot be converted into their active monophosphate form, leading to resistance. **Foscarnet** is a pyrophosphate analog that directly inhibits viral DNA polymerase by binding to the pyrophosphate-binding site. Crucially, it **does not require activation by viral kinases**. Therefore, it remains effective against strains that are deficient in or have mutated thymidine kinase. **Analysis of Incorrect Options:** * **A, B, and C (Acyclovir, Ganciclovir, Famciclovir):** All these agents are nucleoside analogs that require initial phosphorylation by viral-specific enzymes. In the absence of these enzymes, these drugs remain inactive and ineffective. **High-Yield NEET-PG Pearls:** * **Cidofovir** is another drug that bypasses the need for viral kinase (it is a nucleotide analog already containing a phosphate group), but it still requires host cellular kinases. * **Foscarnet Side Effects:** The most common dose-limiting toxicity is **nephrotoxicity**. It is also notorious for causing **electrolyte imbalances** (hypocalcemia, hypomagnesemia, and hypokalemia) and genital ulcerations. * **Drug of Choice:** Foscarnet is the drug of choice for **Acyclovir-resistant HSV/VZV** and **Ganciclovir-resistant CMV**.

Q: What is the mechanism of action of fluoroquinolones?

Inhibits DNA gyrase. **Explanation:** Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin) are bactericidal antibiotics that primarily target bacterial DNA replication. They act by inhibiting two key enzymes: **DNA gyrase (Topoisomerase II)** and **Topoisomerase IV**. DNA gyrase is responsible for introducing negative supercoils to relieve the torsional stress ahead of the replication fork. By inhibiting this enzyme, fluoroquinolones cause double-stranded DNA breaks and prevent replication, leading to cell death. In Gram-negative bacteria, DNA gyrase is the primary target, while in Gram-positive bacteria, Topoisomerase IV (which separates daughter chromosomes) is the main target. **Analysis of Incorrect Options:** * **Option A:** Cell wall synthesis inhibition is the mechanism for Beta-lactams (Penicillins, Cephalosporins), Vancomycin, and Bacitracin. * **Option B:** Protein synthesis inhibition is characteristic of Aminoglycosides, Tetracyclines (30S subunit), Macrolides, and Chloramphenicol (50S subunit). * **Option D:** Interference with intermediary metabolism (antimetabolites) describes Sulfonamides and Trimethoprim, which inhibit folic acid synthesis. **High-Yield Clinical Pearls for NEET-PG:** * **Resistance:** Occurs via mutations in the *gyrA* or *parC* genes or through efflux pumps. * **Adverse Effects:** Most characteristic are **tendon rupture/tendonitis** (especially Achilles) and **QT interval prolongation**. * **Contraindications:** Generally avoided in pregnancy and children (due to potential cartilage damage/arthropathy). * **Pharmacokinetics:** Divalent/trivalent cations (Antacids, Iron, Calcium) decrease their absorption.

Q: Which of the following cephalosporins has activity against methicillin-resistant Staphylococcus aureus?

Ceftobiprole. **Explanation:** The correct answer is **Ceftobiprole**. **1. Why Ceftobiprole is correct:** Traditionally, cephalosporins are ineffective against Methicillin-Resistant *Staphylococcus aureus* (MRSA) because they cannot bind to **PBP-2a**, an altered penicillin-binding protein that mediates resistance [1]. **Ceftobiprole** (along with **Ceftaroline**) belongs to the **5th generation cephalosporins**. These agents possess a unique structure that allows high-affinity binding to PBP-2a, thereby inhibiting cell wall synthesis in MRSA strains. **2. Why other options are incorrect:** * **Ceftriaxone (Option A):** A 3rd generation cephalosporin [1] with excellent gram-negative coverage and CNS penetration, but it lacks activity against MRSA. * **Ceftazidime (Option B):** A 3rd generation cephalosporin primarily known for its potent activity against *Pseudomonas aeruginosa* [2]. It has very poor activity against gram-positive organisms like *S. aureus*. * **Cefuroxime (Option C):** A 2nd generation cephalosporin [1] used for respiratory tract infections and surgical prophylaxis. While it covers Methicillin-Sensitive *S. aureus* (MSSA), it is inactivated by the resistance mechanisms of MRSA. **3. High-Yield Clinical Pearls for NEET-PG:** * **5th Generation Duo:** Remember **Ceftaroline** and **Ceftobiprole** as the "MRSA-active cephalosporins." * **Ceftaroline** is the first FDA-approved cephalosporin for MRSA. * **LAME mnemonic:** Cephalosporins generally do **NOT** cover **L**isteria, **A**typicals (Mycoplasma/Chlamydia), **M**RSA (except 5th gen), and **E**nterococci. * **Ceftobiprole** also maintains activity against *Pseudomonas*, whereas Ceftaroline does not.

Question 1

Which of the following adverse effects is most likely to occur with sulfonamides?

Accepted Answer

Skin reactions

Answer

Neurologic effects including headache, dizziness, and lethargy

Answer

Hematuria

Answer

Fanconi's anemia

Question 2

Ganciclovir is preferred over acyclovir in which of the following conditions?

Accepted Answer

Cytomegalovirus retinitis in AIDS patients

Answer

Herpes simplex keratitis

Answer

Herpes zoster

Answer

Chickenpox

Question 3

Which aminoglycoside has the least toxic effect?

Accepted Answer

Streptomycin

Answer

Ethambutol

Answer

Isoniazid

Answer

Kanamycin

Question 4

All of the following statements about Penicillin Resistance are true, EXCEPT:

Accepted Answer

Alteration in target PBPs is an important resistance mechanism in Gram-negative bacteria.

Answer

Beta-lactamase production is the most common mechanism of resistance.

Answer

Alteration in permeability/penetration of antibiotic causes resistance only in Gram-negative bacteria.

Answer

Beta-lactamase production causes resistance in both Gram-positive and Gram-negative bacteria.

Question 5

What is the mechanism of action of Delamanid?

Accepted Answer

Inhibition of Mycolic acid synthesis

Answer

Inhibition of DNA Gyrase

Answer

Inhibition of Alanine Racemase

Answer

Inhibition of Topoisomerase

Question 6

IV Metronidazole is used in the treatment of which of the following?

Accepted Answer

All of the above

Answer

Pseudomembranous enterocolitis

Answer

Anaerobic bacterial infection

Answer

Amoebiasis

Question 7

A 30-year-old male patient presents with a painful skin rash. Despite antiviral and analgesic treatment, his symptoms have not improved. Viral strains isolated from the patient lack viral phosphorylating enzymes. Which of the following drugs is most likely to be effective in treating this condition?

Accepted Answer

Foscarnet

Answer

Acyclovir

Answer

Ganciclovir

Answer

Famciclovir

Question 8

What is the mechanism of action of fluoroquinolones?

Accepted Answer

Inhibits DNA gyrase

Answer

Inhibits cell wall synthesis

Answer

Inhibits protein synthesis

Answer

Interferes with intermediary metabolism

Question 9

Which of the following cephalosporins has activity against methicillin-resistant Staphylococcus aureus?

Accepted Answer

Ceftobiprole

Answer

Ceftriaxone

Answer

Ceftazidime

Answer

Cefuroxime

Question 10

Which of the following statements is not true regarding sulfonamides?

Accepted Answer

Sulfasalazine is poorly absorbed from the GIT.

Answer

Crystalluria can occur with sulfonamide administration.

Answer

Sulfonamide administration to newborns may cause kernicterus.

Answer

Sulfonamides are of value in the treatment of infections due to Norcardia species.

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?